- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04856657
Targeting Individual Alpha Frequencies to Enhance Perceptual Timing
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The proposed pilot study will assess the feasibility of transcranial alternating current stimulation (tACS) to enhance aspects of attention in people with psychotic disorders.
If a participant agrees to participate in this research, they will be asked to visit the study site to complete the activities listed below. These study activities will take about 5.5 hours to complete. The activities can be divided into up to 3 separate sessions as needed, but all activities should be completed within approximately one week.
Phase 1:
- A clinical interview including an abbreviated MINI, consisting of the mood, mania, suicide, and psychosis modules to either: confirm a diagnosis of a psychotic disorder in Psychosis Subject recruits; or confirm no diagnosis of a psychotic disorder in Control Subject recruits. If any suicidal ideation is expressed on the suicide module, study staff will administer the C-SSRS.
- All participants will complete the Wechsler Test of Adult Reading (WTAR) to obtain an estimate of average IQ, the Brief Assessment of Cognition (BAC app; including Verbal Learning, Digit Sequencing, Token Motor, Semantic Fluency, Symbol Coding, and Tower of London), the Edinburgh Handedness Inventory, and a brief demographic questionnaire.
- Participants with psychosis will complete the PANSS clinical interview to assess psychosis symptoms. Controls will not complete the PANSS.
- Next, participants will undergo a baseline EEG that includes measures of resting EEG (once at the beginning and once more at the end of the session) and a Double-Flash Fusion Illusion Task.
Phase 2:
- Participants will undergo a shortened version of the Double-Flash task without any tACS stimulation.
- Participants will then undergo 3 shortened versions of the Double-Flash Fusion Illusion task while simultaneously undergoing tACS. In counterbalanced order, participants will have tACS set at their IAF (obtained from the subject's resting EEG signal), their IAF + 2Hz and their IAF - 2 Hz. Each task run is expected to last 10-20 minutes. In the first ~1 minute of stimulation before starting the task, we will ask participants to report whether they are perceiving phosphenes. We will turn down the stimulation in .1 mA increments until the participant is no longer perceiving bothersome phosphenes before starting the task. Participants will have a ~40 minute break between task sessions.
- During one of the 40 minute between session breaks, participants will be asked to perform two assessment versions of a time-order frequency judgment task: Sound Sweeps (auditory frequency modulation time-order judgement) and Visual Sweeps (visual gabor frequency modulation time-order judgement).
Following the third stimulation/task session, participants will respond to a questionnaire about the tolerability of the stimulation and whether they experienced any immediate adverse effects.
- Currently, subjects will only undergo Phase 1 of the study to optimally pilot test the task and EEG procedures prior to enrolling subjects to both Phases which involves an experimental manipulation of the Double-Flash task. Phase 2 will be initiated at the discretion of the PI.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55455
- University of Minnesota
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Psychosis Participants:
Inclusion Criteria:
- Meet diagnostic criteria for a psychotic disorder (schizophrenia, schizoaffective disorder, schizophreniform disorder, major depressive disorder with psychotic features, bipolar disorder with psychotic features, psychosis disorder not otherwise specified, or unspecified schizophrenia spectrum disorder), as defined by the MINI (Mini-International Neuropsychiatric Interview)
- Are age 18-64 (inclusive)
- Fluent in written and spoken English
- Have an outpatient status of at least 1 month prior to participation
- Has been on a stable dose of psychiatric medication for at least one month prior to participation (titration to a lower dose of psychotropic medications under supervision of a psychiatrist can be allowed at the discretion of the investigators)
Exclusion Criteria:
- History of seizures or epilepsy
- Metallic cranial plates, screws, or implanted devices
- History of craniotomy
- History of stroke
- History of eczema on scalp
- Pre-existing sores or lesions at sites of tACS electrode placement
- Non-removable facial piercings
- Current or possibility of current pregnancy
- Active suicidal ideation at screening or baseline assessments, or previous intent to act on suicidal ideation with a specific plan, preparatory acts, or an actual suicide attempt within the last 3 months, as indicated by the MINI and/or C-SSRS (All participants will complete the suicide module of the MINI. If participants express any suicidal ideation on the MINI, staff will complete the C-SSRS [Columbia-Suicide Severity Rating Scale].)
- WTAR (Wechsler Test of Adult Reading) standardized score below 70
- Any reason our tCS (transcranial stimulation) or EEG caps cannot be placed on their head
Control Participants:
Inclusion Criteria:
- Are age 18-64 (inclusive)
- Fluent in written and spoken English
Exclusion Criteria:
- Meet diagnostic criteria for a psychotic disorder (schizophrenia, schizoaffective disorder, schizophreniform disorder, major depressive disorder with psychotic features, bipolar disorder with psychotic features, psychosis disorder not otherwise specified, or unspecified schizophrenia spectrum disorder), as defined by the MINI
- Self-reports having a first-degree relative with a psychotic disorder
- History of seizures or epilepsy
- Metallic cranial plates, screws, or implanted devices
- History of craniotomy
- History of stroke
- History of eczema on scalp
- Pre-existing sores or lesions at sites of tACS electrode placement
- Non-removable facial piercings
- Current or possibility of current pregnancy
- Active suicidal ideation at screening or baseline assessments, or previous intent to act on suicidal ideation with a specific plan, preparatory acts, or an actual suicide attempt within the last 3 months, as indicated by the MINI and/or C-SSRS (All participants will complete the suicide module of the MINI. If participants express any suicidal ideation on the MINI, staff will complete the C-SSRS.)
- WTAR standardized score below 70
- Any reason our tCS or EEG caps cannot be placed on their head
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Session 1: tACS at IAPF + 2 Hz
Participants in this arm will undergo tACS at a frequency 2 Hz above their IAPF during stimulation session 1.
They will undergo tACS at a frequency 2 Hz below their IAPF during stimulation session 2.
|
The tACS will be applied with a current of 1-2 mA (milliamperes) via two saline soaked electrode sponges (25 cm²) applied to the back of the head.
The anode will be located at Oz and the cathode will be located at Cz.
Other Names:
|
Session 1: tACS at IAPF - 2 Hz
Participants in this arm will undergo tACS at a frequency 2 Hz below their IAPF during stimulation session 1.
They will undergo tACS at a frequency 2 Hz above their IAPF during stimulation session 2.
|
The tACS will be applied with a current of 1-2 mA (milliamperes) via two saline soaked electrode sponges (25 cm²) applied to the back of the head.
The anode will be located at Oz and the cathode will be located at Cz.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Double Flash Fusion Illusion Task
Time Frame: 2 20-minute task runs (one during tACS at IAPF + 2 Hz and one during tACS at IAPF - 2 Hz)
|
Participants are instructed to fixate their gaze on a central fixation cross.
When the cue appears, a low-luminance disc stimulus flashes on either side (left or right) of the fixation cross.
The disc can flash one or two times.
After the stimulus ends, participants are cued to make a response regarding the number of disc flashes (1 or 2).
Participants will undergo 300 trials.
Participants will be scored on response accuracy (i.e., number of correct responses out of 300 possible responses).
|
2 20-minute task runs (one during tACS at IAPF + 2 Hz and one during tACS at IAPF - 2 Hz)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PSYCH-2021-29530
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
All India Institute of Medical Sciences, BhubaneswarRecruitingTreatment Resistant SchizophreniaIndia
-
Bradley LegaRecruiting
-
King's College LondonSouth London and Maudsley NHS Foundation TrustRecruitingTreatment-resistant Schizophrenia | Healthy Controls | Treatment-responsive SchizophreniaUnited Kingdom
-
University of Sao PauloUnknownRefractory Schizophrenia | Super Refractory SchizophreniaBrazil
-
Ohio State UniversityRecruitingTreatment-resistant SchizophreniaUnited States
-
University Hospital, BrestRecruitingSchizophrenia | Schizophrenia Prodromal | Schizophrenia, ChildhoodFrance
-
NYU Langone HealthNot yet recruitingTreatment-resistant SchizophreniaUnited States
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH)RecruitingTreatment-resistant SchizophreniaUnited States
Clinical Trials on Transcranial alternating current stimulation
-
Universidad Metropolitana de Ciencias de la EducacionRecruitingRehabilitation | Chronic StrokeChile
-
University of MinnesotaNational Institute of Mental Health (NIMH)Recruiting
-
Anhui Medical UniversityRecruitingMagnetic Resonance Imaging | Anxiety Disorder | Transcranial Alternating Current StimulationChina
-
First Affiliated Hospital of Zhejiang UniversityRecruitingConsciousness DisordersChina
-
Hebrew SeniorLifeNational Institute on Aging (NIA); BrightFocus FoundationRecruitingDementia | Alzheimer Disease | Executive Dysfunction | Mobility Limitation | Memory LossUnited States
-
A.J.C. SlooterRadboud University Medical Center; HagaZiekenhuisNot yet recruiting
-
University of PennsylvaniaNot yet recruiting
-
Anhui Medical UniversityRecruitingDisorders of ConsciousnessChina
-
University Hospital Inselspital, BerneCompletedHemispatial NeglectSwitzerland
-
University of ZurichUniversity of LuebeckRecruitingExploiting the Potential of Neural Attentional Control to Overcome Hearing Impairment (NeurAttContr)Hearing Loss | Tinnitus | Attention ImpairedSwitzerland